The Defense Health Agency is conducting market research to identify potential sources capable of providing FDA-approved reagents, consumables, and maintenance for two Quidel Ortho Vision Swift Analyzers located at the 96th Medical Group, Eglin AFB, Florida. The requirement includes providing all specified items on a scheduled basis, along with technical support, software upgrades, and readily available field service engineers. This is a Request for Information for planning purposes only and is not a solicitation for offers. Responses are due by 12:00 P.M. Central Time on April 6, 2026. Based on the responses, the subsequent acquisition may be set aside for small businesses or conducted as a full and open competition.